Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2026-02-21 @ 2:06 PM
Study NCT ID:
NCT02867618
Status:
TERMINATED
Last Update Posted:
2021-07-16
First Post:
2016-08-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Carfilzomib and TGR-1202 in Treatment of R/R Lymphoma
Sponsor:
Columbia University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
AAAP5661
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None